Systematic review / meta-analysis / 2012
Omega-3 fatty acids showed no significant benefit for major depressive disorder.
A meta-analysis evaluated 13 randomized, placebo-controlled trials with 731 participants investigating omega-3 fatty acids for major depressive disorder. Omega-3 treatment demonstrated no significant benefit over placebo for depression severity (SMD = 0.11, 95% CI: -0.04 to 0.26). After adjusting for significant publication bias using the trim-and-fill method, the effect was further diminished (SMD = 0.01, 95% CI: -0.13 to 0.15).
- Study type
- Meta-analysis of randomized controlled trials
- Who was studied
- 731 participants with major depressive disorder across 13 trials
- What was measured
- Depression severity
THE PAPER
Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis.
Bloch MH, Hannestad J. Mol Psychiatry, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.